Anti-CD73 antibody and use thereof
Grant
US12583933B2
Kind: B2
Mar 24, 2026
Assignee
BIOTHEUS INC.
Inventors
Liang Du, Hongyan Zhang, Lina Jin, Yali Chen, Jijun Yuan, Zhenqing Zhang, Xiaoniu Miao, Weifeng Huang, Yunli Jia
Abstract
The present invention relates to the field of disease therapy and immunology. Specifically, disclosed are an anti-CD73 antibody or an antigen-binding fragment thereof, a nucleic acid molecule encoding same, an immunoconjugate comprising same, a bispecific molecule and a pharmaceutical composition, as well as use thereof in enhancing immune response and/or treating tumors.
CPC Classifications
C07K 16/2896
C07K 2317/31
C07K 2317/565
C07K 2317/77
C07K 2317/24
C07K 2317/33
C07K 2317/73
C07K 2317/76
C07K 2317/92
A61P 35/00
G01N 33/57492
G01N 2333/70596
G01N 33/6872
G01N 33/574
A61K 2039/505
Filing Date
2020-08-28
Application No.
17924941
Claims
20